Tata India Pharma & Healthcare Fund vs Mirae Asset Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1208 Cr | ₹2770 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 28 Dec 2015 | 02 Jul 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | Nifty Pharma TRI | BSE Healthcare |
| Turn Over | 26.49% | 15% |
| Expense Ratio | 2.14 | 1.93 |
| Manager | Meeta Shetty | Vrijesh Kasera |
| ISIN Code | INF277K016A9 | INF769K01EA2 |
| Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | Mirae Asset Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Month | 4.66% | 3.77% |
| 6 Month | 16.53% | 16.48% |
| 1 Year | 41.34% | 40.52% |
| 3 Year | 22.4% | 19.46% |
| 5 Year | 27.33% | 28.76% |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 31.82% | 31.5% |
| 3 Year | 32.32% | 30.17% |
| 5 Year | 25.8% | 25.11% |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Year | 6.67% | 23.48% |
| 3 Year | 17.46% | 20.47% |
| 5 Year | 14.22% | 23.92% |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Standard Deviation | 14.23% | 14.65% |
| Sharp | 0.74% | 0.62% |
| Beta | 0.9% | 0.95% |
| Alpha | 2.85% | 0.72% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Name | Meeta Shetty | Vrijesh Kasera |
| Total AUM | ₹17847 Cr | ₹12061 Cr |
| Fund Manage | 5 | 4 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 5.39 | 0.92 |
| Small Cap | 23.46 | 20.21 |
| Large Cap | 40.33 | 43.94 |
| Mid Cap | 30.82 | 34.94 |
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 5.39 | 0.92 |
| Pharmaceuticals & Biotechnology | 76.28 | 81.65 |
| Healthcare Services | 14.31 | 16.07 |
| Fertilizers & Agrochemicals | 0.83 | - |
| Chemicals & Petrochemicals | 0.39 | 1.37 |
| Insurance | 2.14 | - |
| Retailing | 0.66 | - |
Top Comparisons
HDFC Medium Term Debt Fund - Growth Option
3Y Returns5.74%
SUNDARAM MEDIUM DURATION FUND Regular Plan - Growth
3Y Returns3.92%
HSBC Flexi Cap Fund - Regular Growth
3Y Returns18.18%
Parag Parikh Flexi Cap Fund Regular-Growth
3Y Returns16.98%
Kotak NASDAQ 100 Fund of Fund - Regular Plan - Growth
3Y Returns14.5%
Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
3Y Returns8.69%
ITI Balanced Advantage Fund Regular - Growth
3Y Returns8.73%
Franklin India Balanced Advantage Fund- Growth
3Y Returns0%